High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans.
High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis-associated metabolites that distinguish active pulmonary tuberculosis in humans.
复制标题
DOI:
10.1371/journal.pone.0205398
复制
发表时间:
2018
期刊:
影响因子:
3.7
通讯作者:
Ziegler TR
中科院分区:
文献类型:
--
作者:
Collins JM;Walker DI;Jones DP;Tukvadze N;Liu KH;Tran VT;Uppal K;Frediani JK;Easley KA;Shenvi N;Khadka M;Ortlund EA;Kempker RR;Blumberg HM;Ziegler TR
Pulmonary tuberculosis (TB) is a major worldwide health problem that lacks robust blood-based biomarkers for detection of active disease. High-resolution metabolomics (HRM) is an innovative method to discover low-abundance metabolites as putative blood biomarkers to detect TB disease, including those known to be produced by the causative organism, Mycobacterium tuberculosis (Mtb). We used HRM profiling to measure the plasma metabolome for 17 adults with active pulmonary TB disease and 16 of their household contacts without active TB. We used a suspect screening approach to identify metabolites previously described in cell culture studies of Mtb based on retention time and accurate mass matches. The association of relative metabolite abundance in active TB disease subjects compared to their household contacts predicted three Mtb-associated metabolites that were significantly increased in the active TB patients based on accurate mass matches: phosphatidylglycerol (PG) (16:0_18:1), lysophosphatidylinositol (Lyso-PI) (18:0) and acylphosphatidylinositol mannoside (Ac1PIM1) (56:1) (p<0.001 for all). These three metabolites provided excellent classification accuracy for active TB disease (AUC = 0.97). Ion dissociation spectra (tandem MS/MS) supported the identification of PG (16:0_18:1) and Lyso-PI (18:0) in the plasma of patients with active TB disease, though the identity of Ac1PIM1 could not be definitively confirmed. Presence of the Mtb-associated lipid metabolites PG (16:0_18:1) and Lyso-PI (18:0) in plasma accurately identified patients with active TB disease. Consistency of in vitro and in vivo data suggests suitability for exploring these in future studies for possible development as TB disease biomarkers.
登录
查看更多内容
影响因子:
14.9
作者:
Ritchie ME;Phipson B;Wu D;Hu Y;Law CW;Shi W;Smyth GK
通讯作者:
Smyth GK
影响因子:
82.9
作者:
Esmail, Hanif;Lai, Rachel P.;Lesosky, Maia;Wilkinson, Katalin A.;Graham, Christine M.;Coussens, Anna K.;Oni, Tolu;Warwick, James M.;Said-Hartley, Qonita;Koegelenberg, Coenraad F.;Walzl, Gerhard;Flynn, JoAnne L.;Young, Douglas B.;Barry, Clifton E., III;O'Garra, Anne;Wilkinson, Robert J.
通讯作者:
Wilkinson, Robert J.
影响因子:
11.3
作者:
Mishra AK;Driessen NN;Appelmelk BJ;Besra GS
通讯作者:
Besra GS
影响因子:
6.4
作者:
Pai, Madhukar;Schito, Marco
通讯作者:
Schito, Marco
影响因子:
--
作者:
Layre E;Sweet L;Hong S;Madigan CA;Desjardins D;Young DC;Cheng TY;Annand JW;Kim K;Shamputa IC;McConnell MJ;Debono CA;Behar SM;Minnaard AJ;Murray M;Barry CE 3rd;Matsunaga I;Moody DB
通讯作者:
Moody DB